Testing effectiveness (Phase 2)WithdrawnNCT00577668
What this trial is testing
A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD)
Who this might be right for
Multiple Myeloma
University of Arkansas
Showing 20 of 0 results